Cite

HARVARD Citation

    Crist, M. et al. (2017). Examining the bleeding incidences associated with targeted therapies used in metastatic renal cell carcinoma. Critical reviews in oncology/hematology. pp. 151-162. [Online]. 
  
Back to record